Brown Advisory Inc. boosted its position in Clorox Co. (NYSE:CLX) by 8.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,297 shares of the company’s stock after buying an additional 1,083 shares during the period. Brown Advisory Inc.’s holdings in Clorox were worth $1,841,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in CLX. Los Angeles Capital Management & Equity Research Inc. increased its stake in Clorox by 17.2% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 362,192 shares of the company’s stock worth $45,658,000 after buying an additional 53,079 shares during the period. IFP Advisors Inc increased its stake in Clorox by 9.2% in the first quarter. IFP Advisors Inc now owns 11,816 shares of the company’s stock worth $1,490,000 after buying an additional 991 shares during the period. B & T Capital Management DBA Alpha Capital Management purchased a new stake in Clorox during the first quarter worth $1,434,000. Virginia Retirement System purchased a new stake in Clorox during the first quarter worth $5,268,000. Finally, Mn Services Vermogensbeheer B.V. purchased a new stake in Clorox during the first quarter worth $357,000. Hedge funds and other institutional investors own 70.26% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) opened at 126.53 on Friday. The firm’s 50-day moving average is $128.98 and its 200 day moving average is $130.06. Clorox Co. has a 52 week low of $113.37 and a 52 week high of $140.47. The firm has a market capitalization of $16.38 billion, a P/E ratio of 25.72 and a beta of 0.33.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The business’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.44 EPS. Equities research analysts forecast that Clorox Co. will post $5.49 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date is Monday, October 24th. Clorox’s dividend payout ratio is currently 64.91%.
A number of research firms have weighed in on CLX. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, July 12th. Goldman Sachs Group Inc. restated a “neutral” rating and issued a $131.00 target price (up from $125.00) on shares of Clorox in a research report on Friday, July 15th. Deutsche Bank AG restated a “hold” rating and issued a $134.00 target price (up from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Citigroup Inc. upped their target price on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, B. Riley restated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research report on Tuesday, August 9th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $128.90.
In related news, COO Dawn C. Willoughby sold 10,617 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total value of $1,390,933.17. Following the completion of the sale, the chief operating officer now owns 20,353 shares of the company’s stock, valued at $2,666,446.53. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Laura Stein sold 38,882 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. 2.09% of the stock is currently owned by corporate insiders.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.